Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Barbara Tommasi

MPH


Clinical Trial Monitor

I joined OCTO in January 2020 as a Clinical Trial Monitor, having had previous experience working in trial management as a CTA for various trials at Oxford Trauma. 

I currently work on:

A two-part, Phase 1 open-label dose escalation and expansion study to assess safety, pharmacokinetics and clinical activity of NUC-3373, a nucleotide analogue, in participants with advanced solid tumours.